Clinical features of patients with Wilson’s disease and hyperbilirubinemia: Comparison to patients with chronic hepatitis B of severe degree
Chen Tao, Ye Hao, Fang Wenmin, et al.
Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China
Chen Tao, Ye Hao, Fang Wenmin, et al.. Clinical features of patients with Wilson’s disease and hyperbilirubinemia: Comparison to patients with chronic hepatitis B of severe degree[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 486-490.
[1] Roberts EA,Schilsky ML. American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease:an update. Hepatology,2008,47(6):2089-2111. [2] Medici V,Rossaro L,Sturniolo GC. Wilson disease–a practical approach to diagnosis, treatment and follow-up. Dig Liver Dis,2007,39(7):601-609. [3] Shah D. Wilson's disease:hepatic manifestations. Dis Mon, 2014,60(9):465-474. [4] Dalvi A. Wilson's disease:neurological and psychiatric manifestations. Dis Mon,2014,60(9):460-464. [5] Dalvi A,Padmanaban M. Wilson's disease:etiology,diagnosis, and treatment. Dis Mon,2014,60(9):450-459. [6] Schilsky ML. Wilson disease:current status and the future. Biochimie,2009,91(10):1278-1281. [7] Ala A,Schilsky ML. Wilson disease:pathophysiology,diagnosis,treatment,and screening. Clin Liver Dis,2004,8(4):787-805,viii. [8] 中华医学会神经病学分会帕金森病及运动障碍学组,中华医学会神经病学分会神经遗传病学组. 肝豆状核变性的诊断与治疗指南.中华神经科杂志,2008,41(8)∶566-569. [9] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2010年版). 实用肝脏病杂志,2011,14(2):81-89. [10] Liu Y,Zhou H,Guo H,et al. Genetic and clinical analysis in a cohort of patients with Wilson's Disease in Southwestern China. Arch Med Res,2015,19. pii:S0188-4409. [11] Zhvania ML,Gogberashvili KL,Gagoshidze M,et al. Wilson disease with thrombocytopenia(case report). Georgian Med New,2014,237:61-64. [12] Bari Z,Saltik Tem zel IN,Uslu N,et al. Acute liver failure in children:20-year experience. Turk J Gastroenterol,2012,23(2):127-134. [13] Kang KS. Abnormality on liver function test. Pediatr Gastroenterol Hepatol Nutr,2013,16(4):225-232. [14] Bandmann O,Weiss KH,Kaler SG. Wilson's disease and other neurological copper disorders. Lancet Neurol,2015,14(1):103-113. [15] Alexandrova A,Kebis A,Misl'anová C,et al. Copper impairsbiliary epithelial cells and induces protein oxidation and oxidative DNA damage in the isolated perfused rat liver. Exp Toxicol Pathol,2007,58(4):255-261. [16] Wu F,Wang J,Pu C,et al. Wilson's Disease: a comprehensive review of the molecular mechanisms. Int J Mol Sci,2015,16(3): 6419-6431. [17] Braiterman LT,Murthy A,Jayakanthan S,et al. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B. Proc Natl Acad Sci U S A,2014,111(14):E1364-1373. [18] Ferenci P. Phenotype-genotype correlations in patients with Wilson's disease. Ann N Y Acad Sci,2014,1315:1-5. [19] Gu YH,Kodama H,Du SL,et al. Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson′s disease. Clin Genet,2003,64(6):479-484. [20] Wei Z,Huang Y,Liu A,et al. Mutational characterization of ATP7B gene in 103 Wilson's disease patients from Southern China:identification of three novel mutations. Neuroreport,2014,25(14):1075-1080. [21] 刘芸野,谷雷雷,黄道,等. 肝豆状核变性的临床特征及其分子诊断. 诊断学理论与实践,2014,13(3):267-270.